Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
2000 1
2001 7
2002 1
2003 4
2004 4
2005 3
2006 2
2007 2
2008 1
2011 1
2015 1
2017 2
2018 2
2019 2
2020 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history.
Ota K, Murakami S, Ishihara K, Sasaki D, Usui T, Mitsumoto-Kaseida F, Sakamoto K, Kosai K, Hasegawa H, Takazono T, Furumoto A, Asoh N, Yoshimine H, Sawai T, Onizuka M, Makimoto N, Izumikawa K, Mukae H, Kohno S, Yanagihara K. Ota K, et al. Among authors: asoh n. Vaccine X. 2023 Apr;13:100282. doi: 10.1016/j.jvacx.2023.100282. Epub 2023 Mar 17. Vaccine X. 2023. PMID: 36960104 Free PMC article.
Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Maeda H, Gopal Dhoubhadel B, Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Maeda H, et al. Among authors: asoh n. Vaccine. 2022 Sep 2;40(37):5504-5512. doi: 10.1016/j.vaccine.2022.07.041. Epub 2022 Aug 10. Vaccine. 2022. PMID: 35963821
High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors.
Dhoubhadel BG, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Yasunami M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group-Japan (APSG-J). Dhoubhadel BG, et al. Among authors: asoh n. Thorax. 2022 Apr 26;77(11):1121-30. doi: 10.1136/thoraxjnl-2021-217979. Online ahead of print. Thorax. 2022. PMID: 35474029 Free PMC article.
Development of cycling probe based real-time PCR methodology for influenza A viruses possessing the PA/I38T amino acid substitution associated with reduced baloxavir susceptibility.
Osada H, Chon I, Phyu WW, Wagatsuma K, Nagata N, Kawashima T, Sato I, Saito T, Kodo N, Masaki H, Asoh N, Tsuchihashi Y, Shirahige Y, Ono Y, Shimada Y, Hamabata H, Saito K, Saito R. Osada H, et al. Among authors: asoh n. Antiviral Res. 2021 Apr;188:105036. doi: 10.1016/j.antiviral.2021.105036. Epub 2021 Feb 10. Antiviral Res. 2021. PMID: 33577807
Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Sando E, et al. Among authors: asoh n. Vaccine. 2019 May 6;37(20):2687-2693. doi: 10.1016/j.vaccine.2019.04.009. Epub 2019 Apr 8. Vaccine. 2019. PMID: 30975569
Accuracy of High-Throughput Nanofluidic PCR-Based Pneumococcal Serotyping and Quantification Assays Using Sputum Samples for Diagnosing Vaccine Serotype Pneumococcal Pneumonia: Analyses by Composite Diagnostic Standards and Bayesian Latent Class Models.
Kakiuchi S, Suzuki M, Dhoubhadel BG, Furumoto A, Ito H, Matsuki K, Tsuchihashi Y, Asoh N, Yasunami M, Ariyoshi K, Morimoto K. Kakiuchi S, et al. Among authors: asoh n. J Clin Microbiol. 2018 Apr 25;56(5):e01874-17. doi: 10.1128/JCM.01874-17. Print 2018 May. J Clin Microbiol. 2018. PMID: 29444834 Free PMC article.
Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019) 2687-2693].
Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Sando E, et al. Among authors: asoh n. Vaccine. 2020 Apr 9;38(17):3404. doi: 10.1016/j.vaccine.2020.03.031. Epub 2020 Mar 19. Vaccine. 2020. PMID: 32201139 No abstract available.
41 results